Ivan Bièche

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Medicine, Oncology, Molecular Oncology +14

Characterization of a Germ-Line Deletion, Including the Entire <i>INK4/ARF</i> Locus, in a Melanoma-Neural System Tumor Family: Identification of <i>ANRIL</i> , an Antisense Noncoding RNA Whose Expression Coclusters with <i>ARF</i>

Éric Pasmant, Ingrid Laurendeau, Delphine Héron et al. · Cancer Research · 2007 · 614 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

Igor Girault, Sengül Tozlu, Rosette Lidereau et al. · PubMed · 2003 · 357 citations

Life Sciences, Molecular Biology, Oncology +16

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

M.F. Mosele, C. Benedikt Westphalen, A Stenzinger et al. · Annals of Oncology · 2024 · 345 citations · Full text

Medicine, Oncology, Molecular Oncology +12

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

Ivan Bièche, Céline Narjoz, Tarik Asselah et al. · Pharmacogenetics and Genomics · 2007 · 342 citations

Life Sciences, Biochemistry, Molecular Biology +8